BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930 Read more
Urovant Sciences Announces FDA Acceptance of New Drug Application for Vibegron for the Treatment of Overactive Bladder Read more
FDA grants Breakthrough Device Designation for Roche’s Elecsys GALAD score to support earlier diagnosis of HCC Read more
Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19 Read more
Arcturus and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology Read more
Cellectis and Servier Execute the Amendment Confirming the Expansion of Their Collaboration on UCART19 Products Read more